A health-economic evaluation of the SetPoint System®, a neuroimmune modulation device for moderate-to-severe rheumatoid arthritis, was published in the Journal of Medical Economics. The study draws on economic modeling conducted by Wing Tech.

Read More: Taylor & Francis – Health Economics